OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
Marina Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone
Cells (2022) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 33
Marina Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone
Cells (2022) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Li-Nan Chen, Yixuan James Zheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Valentin Feichtenschlager, Li-Nan Chen, Yixuan James Zheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma
Yi Zhou, Qi Shu, Zailin Fu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
Yi Zhou, Qi Shu, Zailin Fu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises
Ioannis Anestopoulos, Sotiris Kyriakou, Venetia Tragkola, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108301-108301
Closed Access | Times Cited: 21
Ioannis Anestopoulos, Sotiris Kyriakou, Venetia Tragkola, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108301-108301
Closed Access | Times Cited: 21
Unravelling the Regulatory Roles of lncRNAs in Melanoma: From Mechanistic Insights to Target Selection
Beatrice Moras, Claudia Sissi
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2126-2126
Open Access
Beatrice Moras, Claudia Sissi
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2126-2126
Open Access
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting
Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1273-1273
Open Access
Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1273-1273
Open Access
LncRNAs and PTEN/PI3K signaling: A symphony of regulation in cancer biology
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 249, pp. 154764-154764
Closed Access | Times Cited: 10
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 249, pp. 154764-154764
Closed Access | Times Cited: 10
The role of Motin family proteins in tumorigenesis—an update
Parisa Amirifar, Joseph L. Kissil
Oncogene (2023) Vol. 42, Iss. 16, pp. 1265-1271
Closed Access | Times Cited: 8
Parisa Amirifar, Joseph L. Kissil
Oncogene (2023) Vol. 42, Iss. 16, pp. 1265-1271
Closed Access | Times Cited: 8
A comprehensive insight into the role of small nucleolar RNAs (snoRNAs) and SNHGs in human cancers
Huldani Huldani, Kumaraswamy Gandla, Mohammed Asiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154679-154679
Closed Access | Times Cited: 8
Huldani Huldani, Kumaraswamy Gandla, Mohammed Asiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154679-154679
Closed Access | Times Cited: 8
Identification of novel disulfidptosis‐related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients
Shengrong Cheng, Xin Wang, Shuhan Yang, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
Shengrong Cheng, Xin Wang, Shuhan Yang, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential
Selim Afşar, Rahamat Unissa Syed, Weam M. A. Khojali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Selim Afşar, Rahamat Unissa Syed, Weam M. A. Khojali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment
Yasen Maimaitiyiming, Linyan Ye, Tao Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4442-4442
Open Access | Times Cited: 9
Yasen Maimaitiyiming, Linyan Ye, Tao Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4442-4442
Open Access | Times Cited: 9
LncRNA HAGLR May Aggravate Melanoma Malignancy Via miR-4644/ASB11 Pathway
Longjun Luo, Wenhui Zhang, Zi Li
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1619-1631
Closed Access | Times Cited: 4
Longjun Luo, Wenhui Zhang, Zi Li
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1619-1631
Closed Access | Times Cited: 4
Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response
Kim Denise Fischer, Shashank Tiwari, Beatrice Thier, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Kim Denise Fischer, Shashank Tiwari, Beatrice Thier, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Epigenetics of Conjunctival Melanoma: Current Knowledge and Future Directions
Karin Flick, Hakan Demirci, F. Yesim Demirci
Cancers (2024) Vol. 16, Iss. 21, pp. 3687-3687
Open Access | Times Cited: 1
Karin Flick, Hakan Demirci, F. Yesim Demirci
Cancers (2024) Vol. 16, Iss. 21, pp. 3687-3687
Open Access | Times Cited: 1
LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
Guangjing Zhang, Zhengxiang Wang, Jie Liu, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Guangjing Zhang, Zhengxiang Wang, Jie Liu, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis
Anlan Hong, Meng Cao, Dongqing Li, et al.
Carcinogenesis (2023) Vol. 44, Iss. 12, pp. 871-883
Open Access | Times Cited: 3
Anlan Hong, Meng Cao, Dongqing Li, et al.
Carcinogenesis (2023) Vol. 44, Iss. 12, pp. 871-883
Open Access | Times Cited: 3
LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway
Yuanzhe Zhu, Huala Wu, Xi Yang, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13654-13666
Open Access | Times Cited: 5
Yuanzhe Zhu, Huala Wu, Xi Yang, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13654-13666
Open Access | Times Cited: 5
Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
PeerJ (2023) Vol. 11, pp. e15172-e15172
Open Access | Times Cited: 2
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
PeerJ (2023) Vol. 11, pp. e15172-e15172
Open Access | Times Cited: 2
The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma
Niels Schaft, Jan Dörrie
Methods in molecular biology (2024), pp. 79-107
Closed Access
Niels Schaft, Jan Dörrie
Methods in molecular biology (2024), pp. 79-107
Closed Access
Echidna: A Bayesian framework for quantifying gene dosage effect impacting phenotypic plasticity
Joy Linyue Fan, Mingxuan Zhang, William E. O’Brien, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joy Linyue Fan, Mingxuan Zhang, William E. O’Brien, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Association of Circular RNA and Long Noncoding RNA Dysregulation to Clinical Response to Immunotherapy in Cutaneous Metastatic Melanoma
Javier Oliver, Juan Luis Onieva, María Garrido-Barros, et al.
(2022)
Open Access | Times Cited: 1
Javier Oliver, Juan Luis Onieva, María Garrido-Barros, et al.
(2022)
Open Access | Times Cited: 1
Peer Review #4 of "Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway (v0.2)"
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
(2023)
Open Access
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
(2023)
Open Access
Peer Review #1 of "Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway (v0.3)"
S Khou
(2023)
Open Access
S Khou
(2023)
Open Access
Peer Review #4 of "Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway (v0.3)"
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
(2023)
Open Access
Zhuo Zhang, Duoli Zhang, Fang Wang, et al.
(2023)
Open Access
